Cabaletta Bio (CABA) Exchange Rate Effect (2024 - 2025)

Cabaletta Bio's (CABA) quarterly Exchange Rate Effect came in at -$8000.0 in Q4 2025, up 60.0% year-on-year from -$5000.0 in Q4 2024, and up 27.27% quarter-over-quarter from -$11000.0 in Q3 2025.

Cabaletta Bio (CABA) Exchange Rate Effect (2024 - 2025) Analysis & Trends

Cabaletta Bio's Exchange Rate Effect history runs 2 years deep, the most recent figure standing at -$8000.0 for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 60.0% year-over-year to -$8000.0 in Q4 2025; TTM through Dec 2025 was $19000.0, a 195.0% increase from a year earlier, with the FY2025 full-year figure at $19000.0, up 195.0% from the prior year.
  • Exchange Rate Effect improved to -$8000.0 in Q4 2025 per CABA's latest filing, from -$11000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $31000.0 in Q2 2025 and bottomed at -$20000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 619,347.27
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 19.32 Mn
4 NuCana 279.75 Bn 279.75 Bn - 14,631.83
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -40.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -900,000.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Cabaletta Bio 182.04 Mn 182.04 Mn - -8,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -8,000.00
Dec 31, 2025 -8,000.00
Sep 30, 2025 -11,000.00
Sep 30, 2025 -11,000.00
Jun 30, 2025 31,000.00
Jun 30, 2025 31,000.00
Mar 31, 2025 7,000.00
Mar 31, 2025 7,000.00
Dec 31, 2024 -20,000.00
Dec 31, 2024 -20,000.00